At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of CT Gel in Subjects With Acne Vulgaris
In Brief
A Phase 3 clinical trial evaluating CT Gel, Clindamycin Gel (clindamycin ), and 2 other interventions for Acne Vulgaris and Acne. Completed, enrolled 1,649 participants across 32 sites in 3 countries.
Detailed Summary
The purpose of this study is to demonstrate the safety and effectiveness of CT Gel in subjects with acne vulgaris. The hypothesis is that CT Gel is superior to Clindamycin Gel, Tretinoin Gel and Vehicle Gel for the treatment of acne vulgaris.
Study Details
Timeline
Interventions
Topical gel consisting of clindamycin 1% and tretinoin 0.025%, applied once daily in the evening for 12 weeks
Clindamycin 1% gel applied topically once daily in the evening for 12 weeks
Tretinoin 0.025% gel applied topically once daily in the evening for 12 weeks
Topical gel without clindamycin or tretinoin applied topically once daily in the evening for 12 weeks